Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras

R G Fenton1, J A Hixon, P W Wright

  • 1Department of Experimental Transplantation and Immunology, Division of Clinical Sciences, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702, USA.

Cancer Research
|August 12, 1998
PubMed

Insights

Oncogenic Ras inhibits the expression of the Fas gene, making Ras-transformed cancer cells resistant to Fas-induced apoptosis and immune destruction. This mechanism promotes tumor survival by evading programmed cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The ras oncogene is crucial in cancer development, regulating growth and host/tumor interactions.
  • Oncogenic Ras influences signal transduction pathways, contributing to uncontrolled cell proliferation.
  • Understanding how Ras affects tumor survival and immune evasion is vital for cancer therapy.

Purpose of the Study:

  • To investigate the role of oncogenic Ras in regulating Fas gene expression and Fas-mediated apoptosis.
  • To determine if Ras-transformed cells are resistant to Fas-induced cell death.
  • To elucidate the mechanism by which Ras promotes tumor survival through immune evasion.

Main Methods:

  • Analysis of Fas mRNA and cell surface Fas expression in Ras-transformed cells versus parental cell lines.
  • Treatment with IFN-gamma and tumor necrosis factor alpha to induce Fas expression.
  • Assays for Fas-induced apoptosis in Ras-transformed cells and controls.
  • Retroviral transduction to generate Ras-transformed cell pools and restore Fas sensitivity.

Main Results:

  • Ras-transformed cells showed significantly inhibited fas mRNA and Fas cell surface expression.
  • Ras-transformed cells were highly resistant to Fas-induced apoptosis, even after cytokine treatment.
  • Restoring Fas expression via cDNA transfection re-sensitized Ras-transformed cells to apoptosis.
  • Oncogenic Ras did not confer general resistance to apoptosis.

Conclusions:

  • Oncogenic Ras actively suppresses Fas gene expression, leading to resistance to Fas-mediated apoptosis.
  • This suppression hinders the induction of apoptosis, even when cytokine signaling pathways are functional.
  • Ras-transformed cells may evade host-mediated immune destruction by downregulating Fas expression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...